PROVIDER PROFILE · NPI 1366426454

Indira Misra HigginsDO PLLC

PRACTICEINDIRA C. MISRA HIGGINS, DO PLLCSee all providers at this practice →

DermatologyBeverly Hills, MII

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

888

Unique beneficiaries

—

Total services

1,521

Distinct HCPCS

Medicare payment

$81K

Peer benchmark

Total Medicare services vs. 340 Dermatology providers in MI — below median (cohort median 2,025).

PRESCRIBING · PART D · 2024

Total Rx claims

1,097

Beneficiaries

—

Total drug cost

$108K

Distinct drugs

Brand share

7.9%

Top prescribed drugs

Ketoconazole239 claims

Hydrocortisone127 claims

Triamcinolone Acetonide95 claims

Mupirocin62 claims

Minoxidil61 claims

QUALITY · MIPS · 2024

Final MIPS score

82.5

Quality

68.7

Cost

0.0

Improvement activities

40.0

Promoting interop.

99.0

Payment adjustment

0.32%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$899

Payment records

By payment type

Food and Beverage$827

Education$72

REFERRAL NETWORK

Where Indira Misra Higgins's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 3 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Biotech Clinical Laboratories Inc Clinical Laboratory · Novi, MI	12	28
Kimberley Behrens Pathology · West Bloomfield, MI	11	24

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
WILLIAM BEAUMONT HOSPITAL	89	395
Michelle Young Pathology · Traverse City, MI	16	40
ARMIN, ALI-REZA	15	52

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history